Ascletis Pharma, Inc. (ASCLF)
1.35
+0.03
(+2.27%)
USD |
OTCM |
Jun 08, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 1.513B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 44.77% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | 4641.22 |
| Price to Book Value | 12.15 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | -- |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 99.85% |
Profile
| Ascletis Pharma, Inc. engages in the research and development, production, marketing, and sale of pharmaceutical products. The company was founded by Jinzi Jason Wu and is headquartered in Hangzhou, China. |
| URL | http://www.ascletis.com |
| Investor Relations URL | N/A |
| HQ State/Province | Zhejiang |
| Sector | Health Care |
| Industry | Biotechnology |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| Ascletis Pharma, Inc. engages in the research and development, production, marketing, and sale of pharmaceutical products. The company was founded by Jinzi Jason Wu and is headquartered in Hangzhou, China. |
| URL | http://www.ascletis.com |
| Investor Relations URL | N/A |
| HQ State/Province | Zhejiang |
| Sector | Health Care |
| Industry | Biotechnology |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |